Role of aldose reductase in TNF-α-induced apoptosis of vascular endothelial cells

Chemico-Biological Interactions

Volumn 143-144, Issue , 2003, Pages 605-612

  Chandra, Deepak ^a   Ramana, Kota V ^a   Friedrich, Brian ^a   Srivastava, Sanjay ^b   Bhatnagar, Aruni ^b   Srivastava, Satish K ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Aldose reductase; Apoptosis; Endothelial cells; ICAM; TNF alpha

Indexed keywords

ALDEHYDE; ALDEHYDE REDUCTASE; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; THYMIDINE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

APOPTOSIS; ATHEROSCLEROSIS; CAROTID ARTERY INJURY; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DNA BINDING; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROTEIN BINDING; RESTENOSIS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ALDEHYDE REDUCTASE; APOPTOSIS; BLOTTING, WESTERN; CELLS, CULTURED; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0037324789     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(02)00191-6     Document Type: Conference Paper

References (22)

1. Mitchell M.E., Sidawy A.N. The pathophysiology of atherosclerosis. Semin. Vasc. Surg. 11:1998;134-141.
2. Kirpichnikov D., Sowers J.R. Diabetes mellitus and diabetes-associated vascular disease. Trends Endocrinol. Metab. 12:2001;225-230.
3. Yamanouchi J., Takatori A., Itagaki S., Kawamura S., Yoshikawa Y. APA hamster model for diabetic atherosclerosis. 2. Analysis of lipids and lipoproteins. Exp. Anim. 49:2000;267-274.
4. Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87:2000;840-844.
5. Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol. Rev. 50:1998;21-33.
6. Srivastava S., Watowich S.J., Petrash J.M., Srivastava S.K., Bhatnagar A. Structural and kinetic determinants of aldehyde reduction by aldose reductase. Biochemistry. 38:1999;42-54.
7. Ramana K.V., Dixit B.L., Srivastava S., Balendirnan G.K., Srivastava S.K. Selective recognition of glutathiolated aldehydes by aldose reductase. Biochemistry. 39:2000;12172-12180.
8. Srivastava S., Liu S.Q., Conklin D.J., Zacarias A., Srivastava S.K., Bhatnagar A. Involvement of aldose reductase in the metabolism of atherogenic aldehydes. Chem. Biol. Interact. 130-132:2001;563-571.
9. Bucala R. Lipid and lipoprotein modification by advanced glycosylation end-products: role in atherosclerosis. Exp. Physiol. 82:1997;327-337.
10. Vincent A.M., Brownlee M., Russell J.W. Oxidative stress and programmed cell death in diabetic neuropathy. Ann. NY Acad. Sci. 959:2002;368-383.
11. Lee A.Y.M., Chung S.K., Chung S.S.M. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the AR gene in the lens. Proc. Natl. Acad. Sci. USA. 92:1995;2780-2784.
12. Koya D., King G.L. Protein kinase C activation and the development of diabetic complications. Diabetes. 47:1998;859-866.
13. Rabinovitch A. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab. Res. Rev. 14:1998;129-151.
14. Aggarwal B.B. Tumour necrosis factors receptor associated signaling molecules and their role in activation of apoptosis, JNK and NF-kappaB. Ann. Rheum. Dis. 59:(Suppl. 1):2000;6-16.
15. Chaturvedi M.M., Mukhopadhyay A., Aggarwal B.B. Assay for redox-sensitive transcription factors. Meth. Enzymol. 319:2000;585-602.
16. Ruef J., Liu S.Q., Bode C., Tocchi M., Srivastava S., Runge M.S., Bhatnagar A. Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury. Arterioscler. Thromb. Vasc. Biol. 20:2000;1745-1752.
17. Yasunari K., Kohno M., Kano H., Minami M., Yoshikawa J. Aldose reductase inhibitor improves insulin-mediated glucose uptake and prevents migration of human coronary artery smooth muscle cells induced by high glucose. Hypertension. 35:2000;1092-1098.
18. Iwata T., Sato S., Jimenez J., McGowan M., Moroni M., Dey A., Ibaraki N., Reddy V.N., Carper D. Osmotic response element is required for the induction of aldose reductase by tumor necrosis factor-alpha. J. Biol. Chem. 274:1999;7993-8001.
19. Ferraris J.D., Williams C.K., Jung K.Y., Bedford J.J., Burg M.B., Garcia-Perez A. ORE, a eukaryotic minimal essential osmotic response element: the aldose reductase gene in hyperosmotic stress. J. Biol. Chem. 271:1996;18318-18321.
20. Choy J.C., Granville D.J., Hunt D.W., McManus B.M. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J. Mol. Cell. Cardiol. 33:2001;1673-1690.
21. Mallat Z., Tedgui A. Apoptosis in the vasculature: mechanisms and functional importance. Br. J. Pharmacol. 130:2000;947-962.
22. Tak P.P., Firestein G.S. NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 107:2001;7-11.